what is considered microdose of semaglutide a a GLP1? , #glp #glp1 #longevity #weightloss #semaglutide Does Microdosing GLP-1s Work? Expert

PLoS ONE 2024;19: e0307212

Interpretation The benefit of GLP-1 RAs exceeded the harms for weight loss in the first 2 years of treatment, yet the net benefit was dependent on individual treatment goals (10% or 5% weight loss) and willingness to accept harms in pursuit of weight loss

The research (Sara Stinson) uses large-scale genetic and metabolic data to show that Alzheimer's shares striking metabolic similarities with conditions such as obesity, type 2 diabetes and cardiovascular disease, whereas Parkinson's often points in the opposite direction

Lets dive deeper into the differences and help you decide which could benefit you the most

Future multicenter, large-sample RCTs incorporating liver transcriptomics and metabolomics are warranted to optimize dosing and treatment duration in MASLD patients with IR